360 related articles for article (PubMed ID: 26471178)
1. Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
van den Bergh WM; Lansink-Hartgring AO; van Duijn AL; Engström AE; Lahpor JR; Slooter AJ
J Cardiothorac Surg; 2015 Oct; 10():128. PubMed ID: 26471178
[TBL] [Abstract][Full Text] [Related]
2. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
3. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
[TBL] [Abstract][Full Text] [Related]
4. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism.
Rose EA; Levin HR; Oz MC; Frazier OH; Macmanus Q; Burton NA; Lefrak EA
Circulation; 1994 Nov; 90(5 Pt 2):II87-91. PubMed ID: 7955291
[TBL] [Abstract][Full Text] [Related]
5. Low stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation.
Menon AK; Götzenich A; Sassmannshausen H; Haushofer M; Autschbach R; Spillner JW
Eur J Cardiothorac Surg; 2012 Aug; 42(2):319-23; discussion 323. PubMed ID: 22398471
[TBL] [Abstract][Full Text] [Related]
6. Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors.
Morgan JA; Brewer RJ; Nemeh HW; Gerlach B; Lanfear DE; Williams CT; Paone G
ASAIO J; 2014; 60(3):284-9. PubMed ID: 24625532
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation management following left ventricular assist device implantation is similar across all provider strategies.
McDavid A; MacBrair K; Emani S; Yu L; Lee PHU; Whitson BA; Lampert BC; Agarwal R; Kilic A
Interact Cardiovasc Thorac Surg; 2018 Jan; 26(1):60-65. PubMed ID: 29049614
[TBL] [Abstract][Full Text] [Related]
8. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
[TBL] [Abstract][Full Text] [Related]
9. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
Boyle AJ; Russell SD; Teuteberg JJ; Slaughter MS; Moazami N; Pagani FD; Frazier OH; Heatley G; Farrar DJ; John R
J Heart Lung Transplant; 2009 Sep; 28(9):881-7. PubMed ID: 19716039
[TBL] [Abstract][Full Text] [Related]
10. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
[TBL] [Abstract][Full Text] [Related]
11. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.
Litzler PY; Smail H; Barbay V; Nafeh-Bizet C; Bouchart F; Baste JM; Abriou C; Bessou JP
Eur J Cardiothorac Surg; 2014 Jan; 45(1):55-9; discussion 59-60. PubMed ID: 23671203
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device.
Slaughter MS; Sobieski MA; Gallagher C; Dia M; Silver MA
Tex Heart Inst J; 2008; 35(3):245-9. PubMed ID: 18941649
[TBL] [Abstract][Full Text] [Related]
13. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
14. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support.
Adatya S; Uriel N; Yarmohammadi H; Holley CT; Feng A; Roy SS; Reding MT; John R; Eckman P; Zantek ND
JACC Heart Fail; 2015 Apr; 3(4):314-22. PubMed ID: 25770404
[TBL] [Abstract][Full Text] [Related]
15. Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?
Pacholewicz J; Kuliczkowski W; Kaczmarski J; Zakliczyński M; Garbacz M; Zembala M; Serebruany V
Cardiology; 2015; 131(3):172-6. PubMed ID: 25967953
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
17. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
[TBL] [Abstract][Full Text] [Related]
18. Computational fluid dynamics analysis of surgical adjustment of left ventricular assist device implantation to minimise stroke risk.
Osorio AF; Osorio R; Ceballos A; Tran R; Clark W; Divo EA; Argueta-Morales IR; Kassab AJ; DeCampli WM
Comput Methods Biomech Biomed Engin; 2013; 16(6):622-38. PubMed ID: 22185643
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
[TBL] [Abstract][Full Text] [Related]
20. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
